Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β
Authors
Keywords
-
Journal
Pharmacological Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-08
DOI
10.1007/s43440-020-00162-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier
- (2019) Hisham F. Bahmad et al. Frontiers in Molecular Neuroscience
- Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
- (2018) Teodoro del Ser et al. JOURNAL OF ALZHEIMERS DISEASE
- The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma
- (2018) Hisham F. Bahmad et al. Oncotarget
- Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells
- (2018) Hisham F. Bahmad et al. Frontiers in Oncology
- GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation
- (2016) K. Gupta et al. CANCER RESEARCH
- Tideglusib induces apoptosis in human neuroblastoma IMR32 cells, provoking sub-G 0 /G 1 accumulation and ROS generation
- (2016) Theodore Lemuel Mathuram et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Cancer stem cell signaling pathways
- (2016) William H. Matsui MEDICINE
- Primary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines
- (2016) Georges Daoud et al. Oncotarget
- Advances in Risk Classification and Treatment Strategies for Neuroblastoma
- (2015) Navin R. Pinto et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells
- (2015) Tarek H. Mouhieddine et al. Frontiers in Neuroscience
- A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
- (2014) Eduardo Tolosa et al. MOVEMENT DISORDERS
- Berberis libanotica Ehrenb Extract Shows Anti-Neoplastic Effects on Prostate Cancer Stem/Progenitor Cells
- (2014) Rabih El-Merahbi et al. PLoS One
- Cell Survival Signaling in Neuroblastoma
- (2013) Michael L. Megison et al. Anti-Cancer Agents in Medicinal Chemistry
- Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma
- (2013) Anna Alisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling
- (2013) D. J. Duffy et al. MOLECULAR CANCER THERAPEUTICS
- Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic Agents
- (2012) Guofang Chen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeting JNK for therapeutic depletion of stem-like glioblastoma cells
- (2012) Ken-ichiro Matsuda et al. Scientific Reports
- Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines
- (2011) Lu Cao et al. BMC GASTROENTEROLOGY
- A Genome-Wide Search for Promoters That Respond to Increased MYCN Reveals Both New Oncogenic and Tumor Suppressor MicroRNAs Associated with Aggressive Neuroblastoma
- (2011) J. M. Shohet et al. CANCER RESEARCH
- Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
- (2011) Juan Manuel Domínguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Self-Renewing Pten-/-TP53-/- Protospheres Produce Metastatic Adenocarcinoma Cell Lines with Multipotent Progenitor Activity
- (2011) Wassim Abou-Kheir et al. PLoS One
- Eckol suppresses maintenance of stemness and malignancies in glioma stem-like cells
- (2011) Kyung-Hwan Hyun et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Emerging Roles of Glycogen Synthase Kinase 3 in the Treatment of Brain Tumors
- (2011) Caroline N. Mills et al. Frontiers in Molecular Neuroscience
- GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
- (2011) Hagit Eldar-Finkelman et al. Frontiers in Molecular Neuroscience
- Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM and ALDH1 in colorectal cancer
- (2010) A Lugli et al. BRITISH JOURNAL OF CANCER
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- CD133 suppresses neuroblastoma cell differentiation via signal pathway modification
- (2010) H Takenobu et al. ONCOGENE
- Characterizing the Contribution of Stem/Progenitor Cells to Tumorigenesis in the Pten−/−TP53−/− Prostate Cancer Model
- (2010) Wassim G. Abou-Kheir et al. STEM CELLS
- Gene Therapy Targeting Nuclear Factor-κB: Towards Clinical Application in Inflammatory Diseases and Cancer
- (2009) Sander Tas et al. CURRENT GENE THERAPY
- Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus
- (2009) Yonatan Y. Mahller et al. PLoS One
- GSK3: a multifaceted kinase in Wnt signaling
- (2009) Dianqing Wu et al. TRENDS IN BIOCHEMICAL SCIENCES
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression and clinical significance of stem cell marker CD133 in human neuroblastoma
- (2008) Qiang-Song Tong et al. World Journal of Pediatrics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now